[Xunlei Limited Tao Thomas Wu Chief Financial Officer Xunlei Announces Unaudited Quarterly Results and Appoints Co-Chief Executive Officer Project Crystal Achieving First Time Revenues from Sales of Crowd-sourced Bandwidth Total Revenues of US$33.5 Million Exceeding High End of Guidance Range SHENZHEN, China, November 18, 2015 (GLOBE NEWSWIRE) Xunlei Limited (Xunlei or the Company) (Nasdaq:XNET), Chinas leading provider]
[CHINA COMMERCIAL CREDIT, INC. FORM 10-Q INDEX Page Number 3 PART I. FINANCIAL INFORMATION 4 Item 1. Financial Statements 4 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 42 Item 3. Quantitative and Qualitative Disclosures About Market Risk 65 Item 4. Controls and Procedures 65 PART II. OTHER INFORMATION 67 Item 1. Legal Proceedings 67] [I, Jingen Ling, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2015 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [I, Long Yi, certify that: 1 I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2015 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jingen Ling Chief Executive Officer] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Long Yi Chief Financial Officer (Principal Financial and Accounting Officer)]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2016 2Q16 Added 16,744 New Subscribers 2Q16 Revenue Up 12.7% YOY to RMB171.5 Million ($27.0 Million) 2Q16 Operating Income Amounted to RMB52.5 Million ($8.3 Million) Conference Call to be Held November 24, 2015 at 8:00 a.m. ET HONG KONG, China, November 23, 2015 ] [FORM 6-K For the month of November 2015 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Form 20-F x o o o Yes o x EXPLANATORY NOTE 2 Results of Operations and Financial Condition Following this cover page are the preliminary unaudited condensed consolidated financial results for the three months and six months ended September 30, 2015]
[CHINA XD PLASTICS COMPANY LIMITED No. 9 Dalian North Road, Haping Road Centralized Industrial Park, Harbin Development Zone, Heilongjiang Province, PRC 150060 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS to be held on December 3, 2015 TO THE STOCKHOLDERS OF CHINA XD PLASTICS COMPANY LIMITED: The Annual Meeting of the Stockholders of China XD Plastics Company Limited, a Nevada corporation (the]
[FORM 10-Q (Mark One) x September 30, 2015 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Ronghua Wang EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Qinghua Liu Qinghua Liu Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]
[CHINA XD PLASTICS COMPANY LIMITED No. 9 Dalian North Road, Haping Road Centralized Industrial Park, Harbin Development Zone, Heilongjiang Province, PRC 150060 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS to be held on December 3, 2015 TO THE STOCKHOLDERS OF CHINA XD PLASTICS COMPANY LIMITED: The Annual Meeting of the Stockholders of China XD Plastics Company Limited, a Nevada corporation (the]
[FORM 10-Q (Mark One) x September 30, 2015 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Ronghua Wang EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Qinghua Liu Qinghua Liu Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]
[SORL Auto Parts Reports Third-Quarter 2015 Financial Results ZHEJIANG, China, Nov. 16, 2015 -- SORL Auto Parts, Inc. (SORL) ("SORL" or the "Company"), a leading manufacturer and distributor of automotive brake systems as well as other key safety-related auto parts in China, announced today its unaudited financial results for the third quarter and nine-month periods ended September 30, 2015. Third] [SORL Auto Parts, Inc. 3rd Quarter FY2015 Financial Results Conference Call Event Date/Time: Nov 16, 2015 / 08:00AM EST Participants Jin Rui Yu, Chief Operating Officer Min Con Lin, Accounting Manager Raymond Lin, Investor Relations Phyllis Huang, Investor Relations Rachel Levine, US Investor Relations Presentation Operator Greetings and welcome to the SORL Auto Parts third quarter 2015 conference call. At] []
[China Sunergy Announces Second Quarter 2015 Financial Results NANJING, China, November 23, 2015 - China Sunergy Co., Ltd. (NASDAQ: CSUN) ( the ), a specialized solar cell and module manufacturer, today announced its financial results for the second quarter . Second Quarter 2015 Financial Highlights · Total revenue · Shipments · Average selling price (“ASP”) · Gross profit · Net] []
[SORL Auto Parts Reports Third-Quarter 2015 Financial Results ZHEJIANG, China, Nov. 16, 2015 -- SORL Auto Parts, Inc. (SORL) ("SORL" or the "Company"), a leading manufacturer and distributor of automotive brake systems as well as other key safety-related auto parts in China, announced today its unaudited financial results for the third quarter and nine-month periods ended September 30, 2015. Third] [SORL Auto Parts, Inc. 3rd Quarter FY2015 Financial Results Conference Call Event Date/Time: Nov 16, 2015 / 08:00AM EST Participants Jin Rui Yu, Chief Operating Officer Min Con Lin, Accounting Manager Raymond Lin, Investor Relations Phyllis Huang, Investor Relations Rachel Levine, US Investor Relations Presentation Operator Greetings and welcome to the SORL Auto Parts third quarter 2015 conference call. At] []
